Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Long-term sperm cryopreservation does not affect pregnancy success

Roshini Claire Anthony
22 Jul 2019

Likelihood of pregnancy following artificial insemination by donor (AID) or in vitro fertilization (IVF) was not negatively affected by using sperm that had been cryopreserved for up to 15 years, according to a study from China.

“[T]he long-term storage of sperm does not appear to affect live birth rates,” said study author Dr Chuan Huang from the Reproductive & Genetic Hospital of CITIC-Xiangya, Human Sperm Bank, Changsha- Hunan, China, who presented the findings at ESHRE 2019.

In this study, sperm stored for up to 15 years was still effective in leading to pregnancy, said co-author Dr HL Wu, also from the Reproductive & Genetic Hospital of CITIC-Xiangya. 

Huang and co-authors assessed the sperm quality of 119,558 specimens at the Hunan Province Human Sperm Bank of China. The duration of cryostorage was divided into three time frames: 0.5–5, 6–10, and 11–15 years.

There was a significant reduction in the frozen-thaw survival rate of the sperm over the 15-year cryopreservation period, from 85.72 to 73.98 percent (p<0.01). [ESHRE 2019, abstract O-018]

The clinical pregnancy rate among women who underwent AID was numerically reduced when using sperm cryopreserved for 11–15 compared with 0.5–5 years (22.32 percent vs 23.09 percent), as was the pregnancy rate following IVF (53.48 percent vs 64.29 percent). Similarly, the live birth rate was also reduced with longer duration of sperm cryopreservation, be it following AID (80.00 vs 82.17 for 11–15 vs 0.5–5 years) or IVF (73.91 percent vs 81.63 percent).  

In contrast, clinical abortion rates increased with longer duration of sperm cryopreservation, in pregnancies following AID (12.00 percent vs 10.06 percent for 11–15 vs 0.5–5 years) or IVF (17.39 percent vs 12.26 percent). 

However, the decreases in clinical pregnancy and live birth rates and increase in clinical abortion rates did not significantly differ between sperm that had been cryopreserved for 6–10 or 11–15 years with that cryopreserved for 0.5–5 years.

Previously published research has reported on successful live births following intrauterine insemination using sperm that had been preserved in liquid nitrogen for 21 and 28 years [Fertil Steril 2005;84:1017] as well as following intracytoplasmic sperm injection/IVF using sperm preserved for about 40 years. [J Assist Reprod Genet 2013;30:743-744]

Unlike some countries that maintain a legal limit as to how long sperm can be cryopreserved to be used for assisted reproduction, according to Wu, China does not impose this limit. 

Despite the lack of impact on pregnancy, Huang and co-authors recommended that “sperm banks provide sperm in their order of cryopreservation” based on the significant reduction in the frozen-thaw survival rate with time. Furthermore, the number of men whose sperm was preserved for up to 15 years in this study was small. This precludes any firm conclusions from being made on the safety of using sperm that has been preserved for that period or longer.

Huang and colleagues cautioned that these results should also not be generalized to the general population, seeing as how the men included in this study were more likely to have better sperm quality than other men.

“Donors at our sperm bank must be in good health according to physical examination and psychological evaluation, and have no familial history of a genetic disease,” said Huang. She also acknowledged that congenital abnormalities following AID or IVF procedures were not accounted for in this study.

 

Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.